IMMA is a women-led Israeli venture, developing the first automated solution for at-home transvaginal self-scanning. IMMA System includes a remote automated easy-to-use ultrasound device with AI-powered image analysis and a dedicated app. IMMA enables women to perform their own transvaginal scans easily, by themselves, for themselves, in the intimacy and comfort of their home. Powering a tech platform in the women’s pelvic health space, IMMA is scalable all along women’s life for many indications including IVF (Medical fertility), natural fertility, hormone-free contraception, endometriosis, myomas, PCOS, cervix length monitoring, early cancer screening, non-touch pelvic exam. The fertility journey is the company first vertical, aiming at increasing access to the IVF Market and increasing IVF success rates. IMMA offers high quality tools for more personalized care and enable fully remote monitoring without compromise: empowering women for better results, her health in her hands, quite literally.